Advanced Therapies Integrates 2026 brings together leaders from across the cell and gene therapy sector to explore the challenges of translating scientific innovation into scalable, commercially viable therapies.
Taking place on 2 December 2026 at ARC West London, the event will focus on the operational, commercial and manufacturing challenges shaping the future of advanced therapies.
TTP's Tom Broughton, Mechanical Engineer and Project Lead, will facilitate the panel discussion, "The Scale up Challenge: Closing the Gap Between Possible and Deliverable?", exploring the challenges of scaling advanced therapy manufacturing, from process transfer and quality to supply chain resilience and workforce capabilities.

